FOXM1 and cancer: Subsequent studies revealed that FOXM1 was aberrantly upregulated in the majority of human cancers (Myatt and Lam, 2007; Wierstra and Alves, 2007) which include liver, breast, prostate, lung, brain, colon, pancreas, testis, bladder, kidney, ovary, uterus, cervix, oral (Gemenetzidis et al., 2009; Waseem et al., 2010), stomach (Li et al., 2009), blood (acute myeloid leukemia; Nakamura et al., 2010), cutaneous melanoma (Huynh et al., 2011), thyroid carcinoma (Ahmed et al., 2012), nasopharyngeal carcinoma (Chen et al., 2012), and esophageal cancer (Gemenetzidis et al., 2009; Hui et al., 2012).